Xiaoling Cheng
Impact in
- Analytical Chemistry top 2%
- Analytical chemistry methods development
- Hematology top 10%
- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Blood groups and transfusion
Papers in ⓘ
- Hematology 33
- Platelet Disorders and Treatments 26
- Blood groups and transfusion 15
- Hemophilia Treatment and Research 13
- Co-authors
- Hongyuan Yan (7 shared papers)Ning Sun (3 shared papers)Gengliang Yang (2 shared papers)James A. Ruth (1 shared paper)Runhui Wu (28 shared papers)Zhenping Chen (22 shared papers)Zhiguo Hu (1 shared paper)Zhihui Zhao (7 shared papers)
- Journals
- British Journal of Haematology (8 papers)Thrombosis Research (3 papers)Frontiers in Pharmacology (3 papers)Haemophilia (3 papers)Lung (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Xiaoling Cheng
60 papers receiving 725 citations
Peers
Comparison fields: 5 of 108
- Analytical Chemistry 228
- Hematology 125
- Health, Toxicology and Mutagenesis 116
- Spectroscopy 97
- Electrochemistry 35
Countries citing papers authored by Xiaoling Cheng
This map shows the geographic impact of Xiaoling Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Cheng more than expected).
Fields of papers citing papers by Xiaoling Cheng
This network shows the impact of papers produced by Xiaoling Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Cheng. The network helps show where Xiaoling Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 87 | |
| 2 | 2008 | 67 | |
| 3 | 2012 | 52 | |
| 4 | 2012 | 38 | |
| 5 | 2013 | 38 | |
| 6 | 2014 | 36 | |
| 7 | 1993 | 33 | |
| 8 | Anticancer effects of Rosmarinic acid in OVCAR-3 ovarian cancer cells are mediated via induction of apoptosis, suppression of cell migration and modulation of lncRNA MALAT-1 expression. | 2019 | 29 |
| 9 | 2022 | 26 | |
| 10 | 2012 | 24 | |
| 11 | 2020 | 19 | |
| 12 | 2015 | 19 | |
| 13 | 2016 | 16 | |
| 14 | 2018 | 15 | |
| 15 | 2017 | 13 | |
| 16 | 2016 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2021 | 10 |
About Xiaoling Cheng
Xiaoling Cheng is a scholar working on Hematology, Transplantation, Genetics, Analytical Chemistry and Applied Microbiology and Biotechnology, having authored 74 papers that have together received 733 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (26 papers), Blood groups and transfusion (15 papers), Hemophilia Treatment and Research (13 papers), Pulmonary Hypertension Research and Treatments (9 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers), Analytical chemistry methods development (6 papers), Blood properties and coagulation (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Analytical Chemistry (228 citations), Hematology (125 citations), Health, Toxicology and Mutagenesis (116 citations), Spectroscopy (97 citations) and Electrochemistry (35 citations). Xiaoling Cheng has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Hongyuan Yan, Ning Sun, Gengliang Yang, James A. Ruth, Runhui Wu, Zhenping Chen, Zhiguo Hu, Zhihui Zhao, Jianguo He and Xiaoling Wang. Their work appears in journals such as British Journal of Haematology, Thrombosis Research, Frontiers in Pharmacology, Haemophilia and Lung.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.